Global Psoriatic Arthritis Drug Market - Industry Dynamics, Market Size, And Opportunity Forecast To 2028
Global Psoriatic Arthritis Drug Market - Industry Dynamics, Market Size, And Opportunity Forecast To 2028
Psoriatic Arthritis Drug Market by End User (Office Building Construction, Retail Construction, Hospitality Construction, Institutional Construction, Other End Users), by North America (United States, Canada, Mexico), by South America (Brazil, Argentina, Rest of South America), by Europe (United Kingdom, Germany, France, Italy, Spain, Russia, Benelux, Nordics, Rest of Europe), by Middle East & Africa (Turkey, Israel, GCC, North Africa, South Africa, Rest of Middle East & Africa), by Asia Pacific (China, India, Japan, South Korea, ASEAN, Oceania, Rest of Asia Pacific) Forecast - is a comprehensive report that provides insights into the market dynamics, including the key drivers, challenges, and opportunities shaping the industry landscape. It also delves into the competitive landscape, highlighting the major players and their strategies.
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
Biologic abatacept (Orencia) was approved in 2017 to treat psoriatic arthritis in adults. It was already approved for rheumatoid arthritis (RA) and for one subtype of juvenile idiopathic arthritis (JIA). Technically called a "selective costimulation modulator," abatacept works by targeting T-lymphocytes (T cells).
Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological advancements, new product launches, and market capital flows are compared across scenarios to demonstrate their impact over the forecast period.
Data collected includes market dynamics, technology outlook, application development, and pricing trends. All of this is fed into a research model, which then produces relevant data for market research. Global market trend analysis is given including historical data, estimates to 2023 and compound annual growth rate (CAGR) forecast to 2028.
Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation.
2023 will be a tough year for much of the global economy, as the ongoing war in Ukraine continues to strain trade, especially in Europe, and the global economy remains reeling from the fallout from the COVID-19 pandemic.
But as China moves ever closer to fully reemerging from three years of government-imposed Covid isolation and reintegrating with the world, economic expectations are high.And with the global economy now facing significant challenges, including energy shortages, slowing growth and high inflation, China’s reopening could provide a much-needed and timely boost.
The report researches and analyzes the influence of the Psoriatic Arthritis Drug industry in the new era of global post-COIVD-19 economy in 2023, and provides in-depth analysis and professional suggestions on the current development.
Market Segment by Product Type
TNF Inhibitors
PDE4 Inhibitors
Interleukin Blockers
Other
Market Segment by Product Application
Mild Psoriatic Arthritis
Moderate Psoriatic Arthritis
Severe Psoriatic Arthritis
Finally, the report provides detailed profile and data information analysis of leading company.
Abbvie
Janssen
Amgen
Pfizer
Eli-lilly
Celgene
Insights and Tools:
We follow a comprehensive process to estimate market size. Key industry dynamics, regulatory scenarios, and segmental dynamics are analyzed to understand their impact on demand over the forecast period. Macroeconomic indicators such as prices, income and demographic changes, demand changes, etc. are considered in estimating market size. We also provide an in-depth profile of the key players and discuss their market shares in the global market to derive the market value. In addition, we have an internal database that is regularly updated with key insights and press releases from key stakeholders in the relevant market.
The data is generally gathered in various arrangements such as charts, graphs, infographics, trends, documents and records from various manufacturers and retailers. Our analyst gather, collect, and interpret such data to form significant databases. Our team then works with large data volumes to analyze core developments, evaluate market estimations, and identify trends.
The market research includes historical and forecast data from like demand, application details, price trends, and company shares by geography, especially focuses on the key regions like United States, European Union, China, and other regions.
Research Objectives
1.To study and analyze the global Psoriatic Arthritis Drug consumption (value) by key regions/countries, product type and application, history data from 2018 to 2022, and forecast to 2028.
2.To understand the structure of Psoriatic Arthritis Drug market by identifying its various subsegments.
3.Focuses on the key global Psoriatic Arthritis Drug manufacturers, to define, describe and analyze the value, market share, market competition landscape, Porter's five forces analysis, SWOT analysis and development plans in next few years.
4.To analyze the Psoriatic Arthritis Drug with respect to individual growth trends, future prospects, and their contribution to the total market.
5.To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
6.To project the consumption of Psoriatic Arthritis Drug submarkets, with respect to key regions (along with their respective key countries).
7.To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
8.To strategically profile the key players and comprehensively analyze their growth strategies.
Global Psoriatic Arthritis Drug Market Research Report 2023, Forecast to 2028
1 Market Study Overview
1.1 Study Objectives
1.2 Psoriatic Arthritis Drug Introduce
1.3 Combined with the Analysis of Macroeconomic Indicators
1.4 Brief Description of Research methods
1.5 Market Breakdown and Data Triangulation
2 Global Trend Summary
2.1 Psoriatic Arthritis Drug Segment by Type
2.1.1 TNF Inhibitors
2.1.2 PDE4 Inhibitors
2.1.3 Interleukin Blockers
2.1.4 Other
2.2 Market Analysis by Application
2.2.1 Mild Psoriatic Arthritis
2.2.2 Moderate Psoriatic Arthritis
2.2.3 Severe Psoriatic Arthritis
2.3 Global Psoriatic Arthritis Drug Market Comparison by Regions (2018-2028)
2.3.1 Global Psoriatic Arthritis Drug Market Size (2018-2028)
2.3.2 North America Psoriatic Arthritis Drug Status and Prospect (2018-2028)
2.3.3 Europe Psoriatic Arthritis Drug Status and Prospect (2018-2028)
2.3.4 China Psoriatic Arthritis Drug Status and Prospect (2018-2028)
2.3.5 Japan Psoriatic Arthritis Drug Status and Prospect (2018-2028)
2.3.6 Southeast Asia Psoriatic Arthritis Drug Status and Prospect (2018-2028)
2.4 Basic Product Information
2.4.1 Basic Product Information & Technology Development History
2.4.2 Product Manufacturing Process
2.4.3 Interview with Major Market Participants
2.4.4 High-end Market Analysis and Forecast
2.5 Coronavirus Disease 2020 (Covid-19): Psoriatic Arthritis Drug Industry Impact
2.5.1 Psoriatic Arthritis Drug Business Impact Assessment - Covid-19
2.5.2 Market Trends and Psoriatic Arthritis Drug Potential Opportunities in the COVID-19 Landscape
2.5.3 Measures / Proposal against Covid-19
3 Competition by Manufacturer
3.1 Global Psoriatic Arthritis Drug Sales and Market Share by Manufacturer (2018-2023)
3.2 Global Psoriatic Arthritis Drug Revenue and Market Share by Manufacturer (2018-2023)
3.3 Global Psoriatic Arthritis Drug Industry Concentration Ratio (CR5 and HHI)
3.4 Top 5 Psoriatic Arthritis Drug Manufacturer Market Share
3.5 Top 10 Psoriatic Arthritis Drug Manufacturer Market Share
3.6 Date of Key Manufacturers Enter into Psoriatic Arthritis Drug Market
3.7 Key Manufacturers Psoriatic Arthritis Drug Key Manufacturers
3.8 Mergers & Acquisitions Planning
4 Analysis of Psoriatic Arthritis Drug Industry Key Manufacturers
4.1 Abbvie
4.1.1 Compan Detail
4.1.2 Abbvie Psoriatic Arthritis Drug Product Introduction, Application and Specification
4.1.3 Abbvie 137 Sales, Price, Cost, Gross Margin, and Revenue (2018-2023)
4.1.4 Main Business Overview
4.1.5 Abbvie News
4.2 Janssen
4.2.1 Compan Detail
4.2.2 Janssen Psoriatic Arthritis Drug Product Introduction, Application and Specification
4.2.3 Janssen Psoriatic Arthritis Drug Sales, Price, Cost, Gross Margin, and Revenue (2018-2023)
4.2.4 Main Business Overview
4.2.5 Abbvie News
4.3 Amgen
4.3.1 Compan Detail
4.3.2 Amgen Psoriatic Arthritis Drug Product Introduction, Application and Specification
4.3.3 Amgen Psoriatic Arthritis Drug Sales, Price, Cost, Gross Margin, and Revenue (2018-2023)
4.3.4 Main Business Overview
4.3.5 Amgen News
4.4 Pfizer
4.4.1 Compan Detail
4.4.2 Pfizer Psoriatic Arthritis Drug Product Introduction, Application and Specification
4.4.3 Pfizer Psoriatic Arthritis Drug Sales, Price, Cost, Gross Margin, and Revenue (2018-2023)
4.4.4 Main Business Overview
4.4.5 Pfizer News
4.5 Eli-lilly
4.5.1 Compan Detail
4.5.2 Pfizer Psoriatic Arthritis Drug Product Introduction, Application and Specification
4.5.3 Eli-lilly Psoriatic Arthritis Drug Sales, Price, Cost, Gross Margin, and Revenue (2018-2023)
4.5.4 Main Business Overview
4.5.5 Eli-lilly News
4.6 Celgene
4.6.1 Compan Detail
4.6.2 Celgene Psoriatic Arthritis Drug Product Introduction, Application and Specification
4.6.3 Celgene Psoriatic Arthritis Drug Sales, Price, Cost, Gross Margin, and Revenue (2018-2023)
4.6.4 Main Business Overview
4.6.5 Celgene News
5 Global Psoriatic Arthritis Drug Market Segment by Big Type
5.1 Global Psoriatic Arthritis Drug Revenue, Sales and Market Share by Big Type (2018-2023)
5.1.1 Global Psoriatic Arthritis Drug Sales and Market Share by Big Type (2018-2023)
5.1.2 Global Psoriatic Arthritis Drug Revenue and Market Share by Big Type (2018-2023)
5.2 TNF Inhibitors Sales Growth Rate and Price
5.2.1 Global TNF Inhibitors Sales Growth Rate (2018-2023)
5.2.2 Global TNF Inhibitors Price (2018-2023)
5.3 PDE4 Inhibitors Sales Growth Rate and Price
5.3.1 Global PDE4 Inhibitors Sales Growth Rate (2018-2023)
5.3.2 Global PDE4 Inhibitors Price (2018-2023)
5.4 Interleukin Blockers Sales Growth Rate and Price
5.4.1 Global Interleukin Blockers Sales Growth Rate (2018-2023)
5.4.2 Global Interleukin Blockers Price (2018-2023)
5.5 Other Sales Growth Rate and Price
5.5.1 Global Other Sales Growth Rate (2018-2023)
5.5.2 Global Other Price (2018-2023)
6 Global Psoriatic Arthritis Drug Market Segment by Big Application
6.1 Global Psoriatic Arthritis Drug Sales Market Share by Big Application (2018-2023)
6.2 Mild Psoriatic Arthritis Sales Growth Rate (2018-2023)
6.3 Moderate Psoriatic Arthritis Sales Growth Rate (2018-2023)
6.4 Severe Psoriatic Arthritis Sales Growth Rate (2018-2023)
7 Global Psoriatic Arthritis Drug Forecast
7.1 Global Psoriatic Arthritis Drug Revenue, Sales and Growth Rate (2023-2028)
7.2 Psoriatic Arthritis Drug Market Forecast by Regions (2023-2028)
7.2.1 North America Psoriatic Arthritis Drug Market Forecast (2023-2028)
7.2.2 Europe Psoriatic Arthritis Drug Market Forecast (2023-2028)
7.2.3 China Psoriatic Arthritis Drug Market Forecast (2023-2028)
7.2.4 Japan Psoriatic Arthritis Drug Market Forecast (2023-2028)
7.2.5 Southeast Asia Psoriatic Arthritis Drug Market Forecast (2023-2028)
7.2.6 Other Regions Psoriatic Arthritis Drug Market Forecast (2023-2028)
7.3 Psoriatic Arthritis Drug Market Forecast by Type (2023-2028)
7.3.1 Global Psoriatic Arthritis Drug Sales Forecast by Type (2023-2028)
7.3.2 Global Psoriatic Arthritis Drug Market Share Forecast by Type (2023-2028)
7.4 Psoriatic Arthritis Drug Market Forecast by Application (2023-2028)
7.4.1 Global Psoriatic Arthritis Drug Sales Forecast by Application (2023-2028)
7.4.2 Global Psoriatic Arthritis Drug Market Share Forecast by Application (2023-2028)
8 Market Analysis
8.1.1 Market Overview
8.1.2 Market Opportunities
8.1.3 Market Risk
8.1.4 Market Driving Force
8.1.5 Porter's Five Forces Analysis
8.1.6 SWOT Analysis
9 Psoriatic Arthritis Drug Related Market Analysis
9.1 Upstream Analysis
9.1.1 Macro Analysis of Upstream Markets
9.1.2 Key Players in Upstream Markets
9.1.3 Upstream Market Trend Analysis
9.1.4 Psoriatic Arthritis Drug Manufacturing Cost Analysis
9.2 Downstream Market Analysis
9.2.1 Macro Analysis of Down Markets
9.2.2 Key Players in Down Markets
9.2.3 Downstream Market Trend Analysis
9.2.4 Sales Channel, Distributors, Traders and Dealers
10 Research Findings and Conclusion
Research Methodology:
Psoriatic Arthritis Drug Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|